{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T03:50:11Z","timestamp":1789617011424,"version":"build-2803163510"},"reference-count":35,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JASN"],"published-print":{"date-parts":[[2017,12]]},"abstract":"\n Diabetic nephropathy is characterized by persistent albuminuria, progressive decline in GFR, and secondary hypertension. MicroRNAs are dysregulated in diabetic nephropathy, but identification of the specific microRNAs involved remains incomplete. Here, we show that the peripheral blood from patients with diabetes and the kidneys of animals with type 1 or 2 diabetes have low levels of microRNA-25 (miR-25) compared with those of their nondiabetic counterparts. Furthermore, treatment with high glucose decreased the expression of miR-25 in cultured kidney cells. In\n db<\/jats:italic>\n \/\n db<\/jats:italic>\n mice, systemic administration of an miR-25 agomir repressed glomerular fibrosis and reduced high BP. Notably, knockdown of miR-25 in normal mice by systemic administration of an miR-25 antagomir resulted in increased proteinuria, extracellular matrix accumulation, podocyte foot process effacement, and hypertension with renin-angiotensin system activation. However, excessive miR-25 did not cause kidney dysfunction in wild-type mice. RNA sequencing showed the alteration of miR-25 target genes in antagomir-treated mice, including the Ras-related gene CDC42.\n In vitro<\/jats:italic>\n , cotransfection with the miR-25 antagomir repressed luciferase activity from a reporter construct containing the CDC42 3\u2032 untranslated region. In conclusion, these results reveal a role for miR-25 in diabetic nephropathy and indicate a potential novel therapeutic target for this disease.\n <\/jats:p>","DOI":"10.1681\/asn.2015091017","type":"journal-article","created":{"date-parts":[[2017,9,18]],"date-time":"2017-09-18T20:55:22Z","timestamp":1505768122000},"page":"3627-3638","source":"Crossref","is-referenced-by-count":52,"title":["Variations in MicroRNA-25 Expression Influence the Severity of Diabetic Kidney Disease"],"prefix":"10.1681","volume":"28","author":[{"given":"Yunshuang","family":"Liu","sequence":"first","affiliation":[{"name":"Heilongjiang Key Laboratory of Anti-Fibrosis Biotherapy, Medical Research Center, Heilongjiang, People\u2019s Republic of China; and"},{"name":"Clinical Laboratory of Hong Qi Hospital, Mudanjiang Medical University, Heilongjiang, People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongzhi","family":"Li","sequence":"additional","affiliation":[{"name":"Heilongjiang Key Laboratory of Anti-Fibrosis Biotherapy, Medical Research Center, Heilongjiang, People\u2019s Republic of China; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jieting","family":"Liu","sequence":"additional","affiliation":[{"name":"Heilongjiang Key Laboratory of Anti-Fibrosis Biotherapy, Medical Research Center, Heilongjiang, People\u2019s Republic of China; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengfei","family":"Han","sequence":"additional","affiliation":[{"name":"Clinical Laboratory of Hong Qi Hospital, Mudanjiang Medical University, Heilongjiang, People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuefeng","family":"Li","sequence":"additional","affiliation":[{"name":"Clinical Laboratory of Hong Qi Hospital, Mudanjiang Medical University, Heilongjiang, People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"He","family":"Bai","sequence":"additional","affiliation":[{"name":"Heilongjiang Key Laboratory of Anti-Fibrosis Biotherapy, Medical Research Center, Heilongjiang, People\u2019s Republic of China; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunlei","family":"Zhang","sequence":"additional","affiliation":[{"name":"Heilongjiang Key Laboratory of Anti-Fibrosis Biotherapy, Medical Research Center, Heilongjiang, People\u2019s Republic of China; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuelian","family":"Sun","sequence":"additional","affiliation":[{"name":"Heilongjiang Key Laboratory of Anti-Fibrosis Biotherapy, Medical Research Center, Heilongjiang, People\u2019s Republic of China; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanjie","family":"Teng","sequence":"additional","affiliation":[{"name":"Heilongjiang Key Laboratory of Anti-Fibrosis Biotherapy, Medical Research Center, Heilongjiang, People\u2019s Republic of China; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yufei","family":"Zhang","sequence":"additional","affiliation":[{"name":"Heilongjiang Key Laboratory of Anti-Fibrosis Biotherapy, Medical Research Center, Heilongjiang, People\u2019s Republic of China; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohuan","family":"Yuan","sequence":"additional","affiliation":[{"name":"Heilongjiang Key Laboratory of Anti-Fibrosis Biotherapy, Medical Research Center, Heilongjiang, People\u2019s Republic of China; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanhui","family":"Chu","sequence":"additional","affiliation":[{"name":"Heilongjiang Key Laboratory of Anti-Fibrosis Biotherapy, Medical Research Center, Heilongjiang, People\u2019s Republic of China; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Binghai","family":"Zhao","sequence":"additional","affiliation":[{"name":"Heilongjiang Key Laboratory of Anti-Fibrosis Biotherapy, Medical Research Center, Heilongjiang, People\u2019s Republic of China; and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2017,9,18]]},"reference":[{"key":"B1-20230819","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1056\/NEJMp058318","article-title":"Chronic kidney disease in the developing world.","volume":"354","author":"Barsoum","year":"2006","journal-title":"N Engl J Med"},{"key":"B2-20230819","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1056\/NEJMc1602469","article-title":"Trends in chronic kidney disease in china.","volume":"375","author":"Zhang","year":"2016","journal-title":"N Engl J Med"},{"key":"B3-20230819","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1007\/s00125-012-2768-x","article-title":"Towards microRNA-based therapeutics for diabetic nephropathy.","volume":"56","author":"Alvarez","year":"2013","journal-title":"Diabetologia"},{"key":"B4-20230819","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/nrneph.2014.74","article-title":"Therapeutic approaches to diabetic nephropathy--beyond the RAS.","volume":"10","author":"Fernandez-Fernandez","year":"2014","journal-title":"Nat Rev Nephrol"},{"key":"B5-20230819","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1056\/NEJM199311113292004","article-title":"The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group.","volume":"329","author":"Lewis","year":"1993","journal-title":"N Engl J Med"},{"key":"B6-20230819","doi-asserted-by":"crossref","first-page":"896861","DOI":"10.1155\/2015\/896861","article-title":"The ACE2\/apelin signaling, microRNAs, and hypertension.","volume":"2015","author":"Chen","year":"2015","journal-title":"Int J Hypertens"},{"key":"B7-20230819","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/ncb1274","article-title":"MicroRNA-dependent localization of targeted mRNAs to mammalian P-bodies.","volume":"7","author":"Liu","year":"2005","journal-title":"Nat Cell Biol"},{"key":"B8-20230819","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/nrg1379","article-title":"MicroRNAs: Small RNAs with a big role in gene regulation.","volume":"5","author":"He","year":"2004","journal-title":"Nat Rev Genet"},{"key":"B9-20230819","doi-asserted-by":"crossref","first-page":"E2851","DOI":"10.1073\/pnas.1407777111","article-title":"Two miRNA clusters, miR-34b\/c and miR-449, are essential for normal brain development, motile ciliogenesis, and spermatogenesis.","volume":"111","author":"Wu","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B10-20230819","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1681\/ASN.2008020162","article-title":"Podocyte-specific loss of functional microRNAs leads to rapid glomerular and tubular injury.","volume":"19","author":"Ho","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"B11-20230819","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1681\/ASN.2008020233","article-title":"Podocyte-specific deletion of dicer alters cytoskeletal dynamics and causes glomerular disease.","volume":"19","author":"Harvey","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"B12-20230819","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1681\/ASN.2008030312","article-title":"Podocyte-selective deletion of dicer induces proteinuria and glomerulosclerosis.","volume":"19","author":"Shi","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"B13-20230819","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/ki.2011.122","article-title":"The inducible deletion of Drosha and microRNAs in mature podocytes results in a collapsing glomerulopathy.","volume":"80","author":"Zhdanova","year":"2011","journal-title":"Kidney Int"},{"key":"B14-20230819","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.1681\/ASN.2015030300","article-title":"MicroRNA-23b targets Ras GTPase-activating protein SH3 domain-binding protein 2 to alleviate fibrosis and albuminuria in diabetic nephropathy.","volume":"27","author":"Zhao","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"B15-20230819","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1681\/ASN.2011050485","article-title":"Inhibiting microRNA-192 ameliorates renal fibrosis in diabetic nephropathy.","volume":"23","author":"Putta","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"B16-20230819","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1038\/ncb1897","article-title":"TGF-beta activates Akt kinase through a microRNA-dependent amplifying circuit targeting PTEN.","volume":"11","author":"Kato","year":"2009","journal-title":"Nat Cell Biol"},{"key":"B17-20230819","doi-asserted-by":"crossref","first-page":"4126","DOI":"10.1096\/fj.08-112326","article-title":"MicroRNA-377 is up-regulated and can lead to increased fibronectin production in diabetic nephropathy.","volume":"22","author":"Wang","year":"2008","journal-title":"FASEB J"},{"key":"B18-20230819","doi-asserted-by":"crossref","first-page":"2634","DOI":"10.1172\/JCI38864","article-title":"Acquisition of the contractile phenotype by murine arterial smooth muscle cells depends on the Mir143\/145 gene cluster.","volume":"119","author":"Boettger","year":"2009","journal-title":"J Clin Invest"},{"key":"B19-20230819","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1101\/gad.1842409","article-title":"MicroRNAs miR-143 and miR-145 modulate cytoskeletal dynamics and responsiveness of smooth muscle cells to injury.","volume":"23","author":"Xin","year":"2009","journal-title":"Genes Dev"},{"key":"B20-20230819","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1038\/cdd.2009.153","article-title":"The knockout of miR-143 and -145 alters smooth muscle cell maintenance and vascular homeostasis in mice: Correlates with human disease.","volume":"16","author":"Elia","year":"2009","journal-title":"Cell Death Differ"},{"key":"B21-20230819","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.ccr.2011.01.001","article-title":"Identification of miRNomes in human liver and hepatocellular carcinoma reveals miR-199a\/b-3p as therapeutic target for hepatocellular carcinoma.","volume":"19","author":"Hou","year":"2011","journal-title":"Cancer Cell"},{"key":"B22-20230819","doi-asserted-by":"crossref","first-page":"12817","DOI":"10.1073\/pnas.1410745111","article-title":"Mutation of Plekha7 attenuates salt-sensitive hypertension in the rat.","volume":"111","author":"Endres","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B23-20230819","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1038\/nature09267","article-title":"Mammalian microRNAs predominantly act to decrease target mRNA levels.","volume":"466","author":"Guo","year":"2010","journal-title":"Nature"},{"key":"B24-20230819","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1159\/000322105","article-title":"Regulation of NADPH oxidase activity is associated with miRNA-25-mediated NOX4 expression in experimental diabetic nephropathy.","volume":"32","author":"Fu","year":"2010","journal-title":"Am J Nephrol"},{"key":"B25-20230819","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1681\/ASN.2011010003","article-title":"Reduced expression of lipoic acid synthase accelerates diabetic nephropathy.","volume":"23","author":"Yi","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"B27-20230819","first-page":"341","article-title":"Activation of small GTPase Ras and renal fibrosis.","volume":"18","author":"Rodr\u00edguez-Pe\u00f1a","year":"2005","journal-title":"J Nephrol"},{"key":"B28-20230819","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s00018-007-7260-2","article-title":"Involvement of small Ras GTPases and their effectors in chronic renal disease.","volume":"65","author":"Mart\u00ednez-Salgado","year":"2008","journal-title":"Cell Mol Life Sci"},{"key":"B29-20230819","doi-asserted-by":"crossref","first-page":"e129","DOI":"10.1159\/000070236","article-title":"Targeting Ras genes in kidney disease.","volume":"93","author":"Hendry","year":"2003","journal-title":"Nephron, Exp Nephrol"},{"key":"B30-20230819","doi-asserted-by":"crossref","first-page":"e2142","DOI":"10.1038\/cddis.2016.51","article-title":"Cdc42 deficiency induces podocyte apoptosis by inhibiting the Nwasp\/stress fibers\/YAP pathway.","volume":"7","author":"Huang","year":"2016","journal-title":"Cell Death Dis"},{"key":"B31-20230819","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1172\/JCI67846","article-title":"Podocyte-specific RAP1GAP expression contributes to focal segmental glomerulosclerosis-associated glomerular injury.","volume":"124","author":"Potla","year":"2014","journal-title":"J Clin Invest"},{"key":"B32-20230819","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.2337\/db13-1412","article-title":"Rap1 ameliorates renal tubular injury in diabetic nephropathy.","volume":"63","author":"Xiao","year":"2014","journal-title":"Diabetes"},{"key":"B33-20230819","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1038\/cr.2016.32","article-title":"CCAR1 5\u2032 UTR as a natural miRancer of miR-1254 overrides tamoxifen resistance.","volume":"26","author":"Li","year":"2016","journal-title":"Cell Res"},{"key":"B34-20230819","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.molcel.2008.05.001","article-title":"MicroRNA-10a binds the 5'UTR of ribosomal protein mRNAs and enhances their translation.","volume":"30","author":"\u00d8rom","year":"2008","journal-title":"Mol Cell"},{"key":"B35-20230819","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1101\/gad.224170.113","article-title":"The IGF2 intronic miR-483 selectively enhances transcription from IGF2 fetal promoters and enhances tumorigenesis.","volume":"27","author":"Liu","year":"2013","journal-title":"Genes Dev"},{"key":"B36-20230819","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.1161\/CIRCULATIONAHA.110.958967","article-title":"MicroRNA-328 contributes to adverse electrical remodeling in atrial fibrillation.","volume":"122","author":"Lu","year":"2010","journal-title":"Circulation"}],"container-title":["Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00001751-201712000-00022","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T19:29:48Z","timestamp":1786130988000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00001751-201712000-00022"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,18]]},"references-count":35,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1681\/asn.2015091017","relation":{},"ISSN":["1046-6673","1533-3450"],"issn-type":[{"value":"1046-6673","type":"print"},{"value":"1533-3450","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,18]]}}}